INSIGHTS ON PHARMACEUTICAL INSPECTION
-
![Virtual Pharma Expo]( "Qualicaps Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging")
Qualicaps Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And PackagingExplore how a new capsule inspection system helps manufacturers overcome labor shortages, increase throughput, and maintain quality while meeting global compliance standards.
-
![XR76 The Next Gen Of X-Ray Inspection]( "XR76 The Next Gen Of X-Ray Inspection")
XR76 The Next Gen Of X-Ray InspectionDiscover how next-generation X-ray inspection improves sensitivity by up to 40% and reduces false rejects by up to 80%, maximizing both product safety and packaging line efficiency.
-
![M6 Tablet Metal Detector]( "M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production")
M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical ProductionEnsure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.
-
![GettyImages-172962854 screen]( "OEE And Product Inspection")
OEE And Product InspectionExplore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.
-
Establishing A Container Closure System5/13/2026
As a trusted partner to both established and emerging drug developers, we support the safe, effective containment and delivery of life-saving and life-enhancing medicines.
-
Nutraceutical Packaging Inspection: Challenges, Technologies, And Solutions For Supplement Manufacturers7/24/2026
Advanced X-ray inspection, metal detection, and checkweighing technologies ensure fill accuracy, eliminate contaminants, and protect nutraceutical brands.
-
A Powerful Non-Destructive Tool For Tablet Characterization10/6/2025
Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.
-
USP <788> Revisions And Why Packaging Matters More Than Ever5/12/2026
Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.
-
Quality Time With Oliver: Guest Michael Dominguez7/15/2026
Build a stronger CCIT strategy with practical guidance on risk assessment, method development, and validation, as well as how to improve collaboration between sponsors and testing laboratories.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
![E-Scan 655 Feature]( "E-Scan 655 Leak Test Instrument Brochure")
Explore the testing process of a completely non-destructive MicroCurrent conductivity test method and the benefits of this non-contact and non-invasive solution for all parenteral and biologic products.
-
![AI Artificial Intelligence]( "Artificial Intelligence")
Our platform combines our experience and expertise with deep learning models to deliver a bespoke solution that enhances the quality inspection process for every customer.
-
![Switch 75]( "Flexible Pharmaceutical Vision Inspection Equipment For Small Batches")
Our Switch 75 comes standard with an integrated de-/renester system, but can also be integrated into your production line via turn table or directly inline. Two inspection carousels allow the inspection of vials and syringes on one machine.
-
![E-Scan 615 Feature]( "High Voltage Leak Testing System")
Discover a MicroCurrent conductivity test method, HVLDmc, that is completely non-destructive to the container and product. Learn in greater detail about this static test and how defects are detected.
-
![PTI owned image]( "Automated Deterministic Inspection Technologies For Complete QC Of Prefilled Syringes")
The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.
